Miller Anestesia

97. Bersten AD, Edibam C, Hunt T, Moran J: Incidence

and mortality of acute lung injury and the acute

respiratory distress syndrome in three Australian

states. Am J Respir Crit Care Med 165:443–448,

2002.

98. Brun-Buisson C, Minelli C, Bertolini G, et al: Epi-

demiology and outcome of acute lung injury in

European intensive care units: Results from the

ALIVE study. Intensive Care Med 30:51–61, 2004.

99. Roupie E, Lepage E, Wysocki M, et al: Prevalence,

etiologies and outcome of the acute respiratory dis-

tress syndrome among hypoxemic ventilated

patients. SRLF collaborative group on mechanical

ventilation. Société de Réanimation de Langue

Française. Intensive Care Med 25:920–929, 1999.

100. Cheung AM, Tansey CM, Tomlinson G, et al: Two-

year outcomes, health care use, and costs of survi-

vors of acute respiratory distress syndrome. Am J

Respir Crit Care Med 174:538–544, 2006.

101. Herridge MS, Cheung AM, Tansey CM, et al: One-

year outcomes in survivors of the acute respiratory

distress syndrome. N Engl J Med 348:683–693,

2003.

102. Meduri GU, Headley S, Kohler G, et al: Persistent

elevation of inflammatory cytokines predicts a poor

outcome in ARDS. Plasma Il-1 beta and Il-6 levels

are consistent and efficient predictors of outcome

over time. Chest 107:1062–1073, 1995.

103. Meduri GU, Kohler G, Headley S, et al: Inflamma-

tory cytokines in the BAL of patients with ARDS:

Persistent elevation over time predicts poor

outcome. Chest 108:1303–1314, 1995.

104. Abraham E: Neutrophils and acute lung injury. Crit

Care Med 31:S195–S199, 2003.

105. Steinberg JM, Schiller HJ, Halter JM, et al: Alveolar

instability causes early ventilator-induced lung

injury independent of neutrophils. Am J Respir Crit

Care Med 169:57–63, 2004.

106. Ware LB, Matthay MA: The acute respiratory dis-

tress syndrome. N Engl J Med 342:1334–1349,

2000.

107. Marini JJ: Evolving concepts in the ventilatory

management of acute respiratory distress syndrome.

Clin Chest Med 17:555–575, 1996.

108. Brower RG, Lanken PN, MacIntyre N, et al: Higher

versus lower positive end-expiratory pressures in

patients with the acute respiratory distress syn-

drome. N Engl J Med 351:327–336, 2004.

109. Meade MO, Cook DJ, Guyatt GH, et al: Ventilation

strategy using low tidal volumes, recruitment

maneuvers, and high positive end-expiratory pres-

sure for acute lung injury and acute respiratory

distress syndrome: A randomized controlled trial.

JAMA 299:637–645, 2008.

110. Mercat A, Richard JC, Vielle B, et al: Positive end-

expiratory pressure setting in adults with acute lung

injury and acute respiratory distress syndrome: A

randomized controlled trial. JAMA 299:646–655,

2008.

111. Gattinoni L, Tognoni G, Pesenti A, et al: Effect of

prone positioning on the survival of patients with

acute respiratory failure. N Engl J Med 345:568–573,

2001.

112. Mancebo J, Fernandez R, Blanch L, et al: A multi-

center trial of prolonged prone ventilation in severe

acute respiratory distress syndrome. Am J Respir

Crit Care Med 173:1233–1239, 2006.

113. Dellinger RP, Zimmerman JL, Taylor RW, et al:

Effects of inhaled nitric oxide in patients with acute

respiratory distress syndrome: Results of a rando-

mized phase II trial: Inhaled nitric oxide in ARDS

study group. Crit Care Med 26:15–23, 1998.

114. Pauwels RA, Buist AS, Ma P, et al: Global strategy

for the diagnosis, management, and prevention of

chronic obstructive pulmonary disease: National

Heart, Lung, and Blood Institute and World Health

Organization global initiative for chronic obstruc-

tive lung disease (GOLD): Executive summary.

Respir Care 46:798–825, 2001.

115. Standards for the diagnosis and care of patients

with chronic obstructive pulmonary disease. Ame-

rican Thoracic Society. Am J Respir Crit Care Med

152:S77–121, 1995.

116. Murray CJ, Lopez AD: Evidence-based health poli-

cy—lessons from the global burden of disease study.

Science 274:740–743, 1996.

117. MacNee W: Pathophysiology of cor pulmonale in

chronic obstructive pulmonary disease. II. Am J

Respir Crit Care Med 150:1158–1168, 1994.

118. Bach PB, Brown C, Gelfand SE, McCrory DC:

Management of acute exacerbations of chronic obs-

tructive pulmonary disease: A summary and

appraisal of published evidence. Ann Intern Med

134:600–620, 2001.

119. Wedzicha JA, Seemungal TA: COPD exacerbations:

Defining their cause and prevention. Lancet

370:786–796, 2007.

120. Brochard L, Mancebo J, Wysocki M, et al: Noninva-

sive ventilation for acute exacerbations of chronic

obstructive pulmonary disease. N Engl J Med

333:817–822, 1995.

121. Plant PK, Owen JL, Elliott MW: Early use of non-

invasive ventilation for acute exacerbations of

chronic obstructive pulmonary disease on general

respiratory wards: A multicentre randomised con-

trolled trial. Lancet 355:1931–1935, 2000.

122. Vitacca M, Clini E, Pagani M, et al: Physiologic

effects of early administered mask proportional

assist ventilation in patients with chronic obs-

tructive pulmonary disease and acute respira-

tory failure. Crit Care Medicine 28:1791–1797,

2000.

123. Wysocki M, Richard JC, Meshaka P: Noninvasive

proportional assist ventilation compared with

noninvasive pressure support ventilation in hyper-

capnic acute respiratory failure. Crit Care Med

30:323–329, 2002.

124. Lim TK: Treatment of severe exacerbation of

chronic obstructive pulmonary disease with mask-

applied continuous positive airway pressure. Respi-

rology 1:189–193, 1996.

125. Gladwin MT, Pierson DJ: Mechanical ventilation of

the patient with severe chronic obstructive pulmo-

nary disease. Intensive Care Med 24:898–910,

1998.

126. Ware LB, Matthay MA: Clinical practice: Acute pul-

monary edema. N Engl J Med 353:2788–2796,

2005.

127. Bersten AD, Holt AW, Vedig AE, et al: Treatment of

severe cardiogenic pulmonary edema with conti-

nuous positive airway pressure delivered by face

mask. N Engl J Med 325:1825–1830, 1991.

128. Lenique F, Habis M, Lofaso F, et al: Ventilatory and

hemodynamic effects of continuous positive airway

pressure in left heart failure. Am J Respir Crit Care

Med 155:500–505, 1997.

129. Masip J, Betbese AJ, Paez J, et al: Non-invasive pres-

sure support ventilation versus conventional

oxygen therapy in acute cardiogenic pulmonary

oedema: A randomised trial. Lancet 356:2126–

2132, 2000.

130. Nava S, Carbone G, DiBattista N, et al: Noninvasive

ventilation in cardiogenic pulmonary edema: A

multicenter randomized trial. Am J Respir Crit Care

Med 168:1432–1437, 2003.

131. Mehta S, Jay GD, Woolard RH, et al: Randomized,

prospective trial of bilevel versus continuous posi-

tive airway pressure in acute pulmonary edema.

Crit Care Med 25:620–628, 1997.

132. Peter JV, Moran JL, Phillips-Hughes J, et al: Effect of

non-invasive positive pressure ventilation (NIPPV)

on mortality in patients with acute cardiogenic pul-

monary oedema: Ameta-analysis. Lancet 367:1155–

1163, 2006.

133. Winck JC, Azevedo LF, Costa-Pereira A, et al:

Efficacy and safety of non-invasive ventilation in

the treatment of acute cardiogenic pulmonary

edema—a systematic review and meta-analysis. Crit

Care 10:R69, 2006.

134. Aurigemma GP, Gaasch WH: Clinical practice:

Diastolic heart failure. N Engl J Med 351:1097–

1105, 2004.

Asistencia respiratoria

2663

Seccíón VII

Cuidados críticos